Skip to content

The Effect Of A Neurodynamic Treatment On Nerve Conduction In Clients With Low Back Pain

The Effect Of A Neurodynamic Treatment On Nerve Conduction In Clients With Low Back Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01402895
Enrollment
9
Registered
2011-07-26
Start date
2011-05-31
Completion date
2011-10-31
Last updated
2012-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Keywords

Nerve conduction, H-reflex, mobilizations, with neurodynamic component

Brief summary

The purpose of this study is to determine if a certain treatment for low back pain can change the way nerves in the leg send messages. Specifically, the investigators will examine whether a particular type of physical therapy treatment for individuals with low back pain (neurodynamic techniques) changes the speed that nerves send/receive signals to/from the leg, as compared to a different physical therapy treatment.

Interventions

OTHERExercise

Transversus abdominus exercise

OTHERMobilizations

The physiotherapist will perform mobilizations to the L-spine and SI joints with the participant in a specific position.

Sponsors

McMaster University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Males and females aged 18 years and older * Participants who can speak English and read, understand, and fill out the consent form and questionnaires * Participants will have a certain level of low back pain graded numerically, with or without radiation to the leg * Clinical decision (by same individual) as safe to participate in study based on subjective history and objective examination.

Exclusion criteria

* An inability to tolerate sitting for 10 minutes * Nerve conduction disorders diagnosed by a physician such as, diabetes or MS * Current participant in an investigational drug study (within past 3 months)

Design outcomes

Primary

MeasureTime frameDescription
Change in nerve conduction studiesChange from baseline after intervention, on average 1.5 hours after baseline measureMotor conduction of the tibial nerve; Sensory conduction of the sural nerve; H-reflex, H:M ratio (soleus muscle)

Secondary

MeasureTime frame
Change of knee extension in sitting slump testChange from baseline after intervention, on average 1.5 hours after baseline measure
Change in score of Visual Analog Scale for painChange from baseline after intervention, on average 1.5 hours after baseline measure

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026